FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2897474789> ?p ?o ?g. }

• W2897474789 endingPage "e0205491" @default.
• W2897474789 startingPage "e0205491" @default.
• W2897474789 abstract "Robust preclinical testing is essential to predict clinical safety and efficacy and provide data to determine safe dose for first-in-man studies. There are a growing number of examples where the preclinical development of drugs failed to adequately predict clinical adverse events in part due to their assessment with inappropriate preclinical models. Preclinical investigations of T cell receptor (TCR)-based immunotherapies prove particularly challenging as these biologics are human-specific and thus the conventional testing in animal models is inadequate. As these molecules harness the full force of the immune system, and demonstrate tremendous potency, we set out to design a preclinical package that would ensure adequate evaluation of these therapeutics. Immune Mobilising Monoclonal TCR Against Cancer (ImmTAC) molecules are bi-specific biologics formed of an affinity-enhanced TCR fused to an anti-CD3 effector function. ImmTAC molecules are designed to activate human T lymphocytes and target peptides within the context of a human leukocyte antigen (HLA), thus require an intact human immune system and peptidome for suitable preclinical screening. Here we draw upon the preclinical testing of four ImmTAC molecules, including IMCgp100, the first ImmTAC molecule to reach the clinic, to present our comprehensive, informative and robust approach to in vitro preclinical efficacy and safety screening. This package comprises a broad range of cellular and molecular assays using human tissues and cultured cells to test efficacy, safety and specificity, and hence predict human responses in clinical trials. We propose that this entirely in vitro package offers a potential model to be applied to screening other TCR-based biologics." @default.
• W2897474789 created "2018-10-26" @default.
• W2897474789 creator A5005426443 @default.
• W2897474789 creator A5008982465 @default.
• W2897474789 creator A5012026379 @default.
• W2897474789 creator A5015290004 @default.
• W2897474789 creator A5023113041 @default.
• W2897474789 creator A5023514783 @default.
• W2897474789 creator A5027911501 @default.
• W2897474789 creator A5028943079 @default.
• W2897474789 creator A5029346258 @default.
• W2897474789 creator A5029353304 @default.
• W2897474789 creator A5029495946 @default.
• W2897474789 creator A5029606221 @default.
• W2897474789 creator A5029646740 @default.
• W2897474789 creator A5032425529 @default.
• W2897474789 creator A5037431765 @default.
• W2897474789 creator A5043641854 @default.
• W2897474789 creator A5046364897 @default.
• W2897474789 creator A5046841625 @default.
• W2897474789 creator A5052764700 @default.
• W2897474789 creator A5053886744 @default.
• W2897474789 creator A5062031466 @default.
• W2897474789 creator A5067282180 @default.
• W2897474789 creator A5067438453 @default.
• W2897474789 creator A5071548337 @default.
• W2897474789 creator A5083899103 @default.
• W2897474789 creator A5086811457 @default.
• W2897474789 date "2018-10-15" @default.
• W2897474789 modified "2023-09-27" @default.
• W2897474789 title "An approved in vitro approach to preclinical safety and efficacy evaluation of engineered T cell receptor anti-CD3 bispecific (ImmTAC) molecules" @default.
• W2897474789 cites W1519645049 @default.
• W2897474789 cites W1572378903 @default.
• W2897474789 cites W1705666194 @default.
• W2897474789 cites W1942450988 @default.
• W2897474789 cites W1971485969 @default.
• W2897474789 cites W1983412131 @default.
• W2897474789 cites W2000294386 @default.
• W2897474789 cites W2001578637 @default.
• W2897474789 cites W2002250199 @default.
• W2897474789 cites W2014018866 @default.
• W2897474789 cites W2014275356 @default.
• W2897474789 cites W2017270259 @default.
• W2897474789 cites W2020312840 @default.
• W2897474789 cites W2022046221 @default.
• W2897474789 cites W2041515126 @default.
• W2897474789 cites W2044692977 @default.
• W2897474789 cites W2066671159 @default.
• W2897474789 cites W2070748533 @default.
• W2897474789 cites W2078607441 @default.
• W2897474789 cites W2089377837 @default.
• W2897474789 cites W2092468599 @default.
• W2897474789 cites W2093966230 @default.
• W2897474789 cites W2094945699 @default.
• W2897474789 cites W2094970392 @default.
• W2897474789 cites W2097995306 @default.
• W2897474789 cites W2107925822 @default.
• W2897474789 cites W2108454894 @default.
• W2897474789 cites W2117960143 @default.
• W2897474789 cites W2141989396 @default.
• W2897474789 cites W2142959209 @default.
• W2897474789 cites W2143626441 @default.
• W2897474789 cites W2150928170 @default.
• W2897474789 cites W2234384516 @default.
• W2897474789 cites W2263313156 @default.
• W2897474789 cites W2345568581 @default.
• W2897474789 cites W2460196807 @default.
• W2897474789 cites W2560367415 @default.
• W2897474789 cites W2611831543 @default.
• W2897474789 cites W2754562068 @default.
• W2897474789 cites W2802912386 @default.
• W2897474789 doi "https://doi.org/10.1371/journal.pone.0205491" @default.
• W2897474789 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6188753" @default.
• W2897474789 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30321203" @default.
• W2897474789 hasPublicationYear "2018" @default.
• W2897474789 type Work @default.
• W2897474789 sameAs 2897474789 @default.
• W2897474789 citedByCount "48" @default.
• W2897474789 countsByYear W28974747892019 @default.
• W2897474789 countsByYear W28974747892020 @default.
• W2897474789 countsByYear W28974747892021 @default.
• W2897474789 countsByYear W28974747892022 @default.
• W2897474789 countsByYear W28974747892023 @default.
• W2897474789 crossrefType "journal-article" @default.
• W2897474789 hasAuthorship W2897474789A5005426443 @default.
• W2897474789 hasAuthorship W2897474789A5008982465 @default.
• W2897474789 hasAuthorship W2897474789A5012026379 @default.
• W2897474789 hasAuthorship W2897474789A5015290004 @default.
• W2897474789 hasAuthorship W2897474789A5023113041 @default.
• W2897474789 hasAuthorship W2897474789A5023514783 @default.
• W2897474789 hasAuthorship W2897474789A5027911501 @default.
• W2897474789 hasAuthorship W2897474789A5028943079 @default.
• W2897474789 hasAuthorship W2897474789A5029346258 @default.
• W2897474789 hasAuthorship W2897474789A5029353304 @default.
• W2897474789 hasAuthorship W2897474789A5029495946 @default.
• W2897474789 hasAuthorship W2897474789A5029606221 @default.
• W2897474789 hasAuthorship W2897474789A5029646740 @default.
• W2897474789 hasAuthorship W2897474789A5032425529 @default.

• next